Spectrum of Factors Triggering Endothelial Dysfunction in PIH

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Research
• Biochemistry

Background:

• Pre-eclampsia (PE) is a significant cause of maternal and fetal mortality.
• The exact causes and mechanisms of PE remain unclear.
• Endothelial Dysfunction (ED) is recognized as a crucial factor in the development of PE.

Purpose of the Study:

• To investigate circulating levels of Malondialdehyde (MDA), Ferric Reducing Ability of Plasma (FRAP), Tumor Necrosis Factor-alpha (TNF-α), soluble Fms-like tyrosine kinase-1 (sFlt-1), Vascular Endothelial Growth Factor (VEGF), Placental Growth Factor (PlGF), and Nitric Oxide (NO).
• To determine the role of these factors in endothelial dysfunction associated with PE.

Main Methods:

• A comparative study involving 100 normotensive pregnant women (N), 100 preeclamptic women (PE), and 100 eclamptic women (E) in their third trimester.
• Analysis of MDA, FRAP, TNF-α, sFlt-1, VEGF, PlGF, and NO levels.
• Statistical analysis using Analysis of Variance (ANOVA).

Main Results:

• PE and E groups exhibited significantly higher levels of MDA, TNF-α, and sFlt-1 compared to controls.
• PE and E groups showed significantly lower levels of FRAP, VEGF, PlGF, and NO compared to controls.
• Eclamptic patients (E) had higher MDA, TNF-α, sFlt-1 and lower FRAP, VEGF, PlGF, NO than preeclamptic patients (PE).

Conclusions:

• Oxidative stress and an imbalance between anti-angiogenic and pro-angiogenic factors are present in Pregnancy-Induced Hypertension (PIH).
• This imbalance is directly linked to endothelial dysfunction, a hallmark of PE.
• Oxidative stress markers, VEGF, PlGF, and sFlt-1 can serve as predictive markers for the onset and progression of PE.